This article is from the source 'rtcom' and was first published or seen on . It last changed over 40 days ago and won't be checked again for changes.
You can find the current article at its original source at https://www.rt.com/business/522832-coronavirus-vaccination-costs-who/
The article has changed 3 times. There is an RSS feed of changes available.
| Version 0 | Version 1 |
|---|---|
| Another $45 BILLION needed next year to vaccinate most adults across the globe – World Health Organization | Another $45 BILLION needed next year to vaccinate most adults across the globe – World Health Organization |
| (4 months later) | |
| The global COVAX program for developing and distributing coronavirus vaccines is $19 billion short of its $22 billion target this year, according to World Health Organization (WHO) head Tedros Adhanom Ghebreyesus. | The global COVAX program for developing and distributing coronavirus vaccines is $19 billion short of its $22 billion target this year, according to World Health Organization (WHO) head Tedros Adhanom Ghebreyesus. |
| He said at a briefing that a further $35 billion to $45 billion will be needed next year to ensure that most adults around the world are immunized. | He said at a briefing that a further $35 billion to $45 billion will be needed next year to ensure that most adults around the world are immunized. |
| The WTO chief urged G7 nations to fund the global coronavirus recovery, saying the crisis cannot be resolved worldwide if they do not step up. “The G7 countries could mobilize a substantial portion of these funds themselves, and lead a global effort to accelerate Covid-19 vaccination around the world. | The WTO chief urged G7 nations to fund the global coronavirus recovery, saying the crisis cannot be resolved worldwide if they do not step up. “The G7 countries could mobilize a substantial portion of these funds themselves, and lead a global effort to accelerate Covid-19 vaccination around the world. |
| “COVAX (the global alliance to ensure equitable access to Covid-19 vaccines) urgently needs 20 million doses during the second quarter of 2021 to cover interruptions in supply triggered by increased demands for vaccines in India where COVAX’s main supplier of the AstraZeneca product is based,” he said. | “COVAX (the global alliance to ensure equitable access to Covid-19 vaccines) urgently needs 20 million doses during the second quarter of 2021 to cover interruptions in supply triggered by increased demands for vaccines in India where COVAX’s main supplier of the AstraZeneca product is based,” he said. |
| India reported more than 357,000 new Covid infections on Tuesday, bringing the total to over 20 million cases in the country, according to Health Ministry data. | India reported more than 357,000 new Covid infections on Tuesday, bringing the total to over 20 million cases in the country, according to Health Ministry data. |
| For more stories on economy & finance visit RT's business section | For more stories on economy & finance visit RT's business section |
| Dear readers and commenters, | |
| We have implemented a new engine for our comment section. We hope the transition goes smoothly for all of you. Unfortunately, the comments made before the change have been lost due to a technical problem. We are working on restoring them, and hoping to see you fill up the comment section with new ones. You should still be able to log in to comment using your social-media profiles, but if you signed up under an RT profile before, you are invited to create a new profile with the new commenting system. | |
| Sorry for the inconvenience, and looking forward to your future comments, | |
| RT Team. |